Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

PerkinElmer Acquires JN Macri Technologies and NTD Labs
Jul 2006
BOSTON, July 27, 2006 -- Health science and photonics technology developer PerkinElmer Inc. announced today it has completed the acquisition of JN Macri Technologies LLC and that it has acquired NTD Laboratories Inc., based in Huntington Station, N.Y. The purchase price for both transactions was approximately $56.65 million.

Macri holds and licenses global patents related to free beta human chorionic gonadotropin (free beta-hCG), a peptide hormone produced in the early stage of pregnancy that is widely recognized as a critical biomarker for first-trimester prenatal risk assessment. NTD is a reference laboratory specializing in prenatal risk assessment. It offers laboratory developed and validated testing under the brand name UltraScreen, of which free beta-hCG is a vital component.

PerkinElmer said in a statement that the agreement builds on recent announcements related to its screening and diagnostics strategies. These include a global licensing agreement to develop assay kits for the ADAM12 biochemical marker, which has broad potential in maternal health screening for fetal chromosomal abnormalities; and the securing of global rights for PP13 (placental protein 13), a new prospective biomarker for identifying patients at risk for pre-eclampsia in the first trimester.
The technology covered under the agreement also includes software that utilizes free hCGa measurements to calculate the risk of a fetus having chromosomal abnormalities.

"This acquisition provides an opportunity to strengthen our position with clinicians and our existing laboratory partners as a result of NTD's strong and established relationships with maternal health care providers," said Robert F. Friel, president, PerkinElmer Life and Analytical Sciences. "We expect this agreement will accelerate PerkinElmer's own maternal health research and development initiatives, by giving us the ability to better understand first-hand the needs of the clinical community. Our future plans include the introduction of the free beta-hCG biomarker, which is used throughout Europe, on PerkinElmer's proprietary platforms, further extending our maternal health solutions."

For more information, visit:

The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
free beta human chorionic gonadotropinfree beta-hCGhealth scienceJ.N. Macri TechnologiesNews & FeaturesNTD Laboratoriespeptide hormonePerkinElmerphotonics

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.